CVRx, Inc. (CVRX): Price and Financial Metrics


CVRx, Inc. (CVRX): $6.12

0.11 (+1.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CVRX Stock Price Chart Interactive Chart >

Price chart for CVRX

CVRX Price/Volume Stats

Current price $6.12 52-week high $27.42
Prev. close $6.01 52-week low $4.60
Day low $5.88 Volume 47,100
Day high $6.38 Avg. volume 128,194
50-day MA $5.83 Dividend yield N/A
200-day MA $9.82 Market Cap 125.46M

CVRx, Inc. (CVRX) Company Bio


CVRx, Inc. develops an implantable technology for the treatment of high blood pressure/hypertension and heart failure patients. It offers BAROSTIM NEO, a neuro-modulation therapy that triggers the body's natural reflex to regulate blood pressure and the underlying causes of the progression of heart failure, which is delivered through a long-lasting implant system, and customized to each patient's individual therapy needs. The company serves patients and healthcare professionals. CVRx, Inc. was incorporated in 2000 and is based in Minneapolis, Minnesota. It has operations in the United States, the United Kingdom, the Netherlands, Italy, Germany, and internationally.


CVRX Latest News Stream


Event/Time News Detail
Loading, please wait...

CVRX Latest Social Stream


Loading social stream, please wait...

View Full CVRX Social Stream

Latest CVRX News From Around the Web

Below are the latest news stories about CVRx Inc that investors may wish to consider to help them evaluate CVRX as an investment opportunity.

2 ‘Strong Buy’ Stocks Insiders Are Snapping Up Right Now

While the long-term outlook may predict a return to bullish conditions, for now investors have to contend with increased uncertainty and volatility. What they need is a sign, some signal to indicate stocks that are going to get through the current market environment. Insider trades are a common favorite among the signals available to investors, and for good reason. Corporate insiders – really, just company officers, positioned at the upper levels of management or the Boards, with an ‘inside’ view of everything behind the company and the stock – don’t trade lightly.

Michael Marcus on TipRanks | February 25, 2022

CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

Fourth Quarter 2021 Revenue of $3.7 million, a 75% Increase Over Prior Year Fourth Quarter 2021 Revenue of $3.7 million, a 75% Increase Over Prior Year

GlobeNewswire | February 15, 2022

CVRx GAAP EPS of -$0.52 misses by $0.07, revenue of $3.7M misses by $0.07M

CVRx press release (CVRX): Q4 GAAP EPS of -$0.52 misses by $0.07.Revenue of $3.7M (+76.2% Y/Y) misses by $0.07M.

Seeking Alpha | February 15, 2022

CVRx to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 15, 2022

MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release fourth quarter and full year 2021 financial and operating results after market close on Tuesday, February 15, 2022. The Company will host a conference call to review its results at 5:30 p.m. Eastern Time the same

Yahoo | February 1, 2022

CVRx sees Q4, FY 2021 and Q1 2022 revenue below consensus

CVRx <> announces preliminary Q4 and FY 2021 revenue results, and provided a 2022 business outlook

Seeking Alpha | January 10, 2022

Read More 'CVRX' Stories Here

CVRX Price Returns

1-mo 0.99%
3-mo 0.00%
6-mo -49.88%
1-year -75.96%
3-year N/A
5-year N/A
YTD -49.96%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.3967 seconds.